| Zeit | Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 23.02. | Norva24 Group AB: Revenue and profit growth continues | 72 | GlobeNewswire (Europe) | Year-end January-December 2023
October-December 2023Total operating revenue amounted to NOK 855.7 million (719.5), an increase of 18.9%. Currency adjusted organic growth was 5.2%.Revenue from customer... ► Artikel lesen | |
| 23.02. | Clinical Laserthermia Systems AB: Clinical Laserthermia Systems AB publishes Year-end report January - December 2023 | 88 | GlobeNewswire (Europe) | Summary of the interim report (relates to the Group)
Full year (01/01/2023-12/31/2023)
Net sales totaled SEK 8,273,000 (SEK 6,268,000).
Operating profit/loss totaled SEK -65,933,000 (SEK... ► Artikel lesen | |
| 23.02. | Cyber Security 1 AB: CYBER1 Q4 REPORT 2023: CYBER1 concludes 2023 with a strong fourth quarter | 87 | GlobeNewswire (Europe) | Stockholm, Sweden- 23rd February 2024 - Cyber Security 1 AB (publ) ("The Company") ("CYBER1") (Nasdaq First North: CYB1) has released its Q4 2023 report, detailing a quarterly revenue growth of 16%... ► Artikel lesen | |
| 23.02. | ZignSec AB: Year-end Report 2023 | 112 | GlobeNewswire (Europe) | With interim report for the period 1 October 2023 to 31 December 2023
Full year 2023 in summaryNet revenue amounted to SEK 84.7 (89.9) million, a decrease of 6% compared with the corresponding period... ► Artikel lesen | |
| 23.02. | FM Mattsson Mora Group AB: Year end report January-December 2023 | 89 | GlobeNewswire (Europe) | October-December 2023Net sales were 449.6 MSEK (459.9), a decrease of 2.2% compared to the equivalent quarter in 2023. Organic growth was -4.4%.EBITA was 23.1 MSEK (46.6), an EBITA margin of 5.1% (10.1).... ► Artikel lesen | |
| 23.02. | Seafire AB: Seafire year-end report 2023: Weak margin, but strong cash flow towards the year-end | 104 | GlobeNewswire (Europe) | Revenue increased by 8% to SEK 227 million (210), while operating profit, adjusted EBITA, amounted to SEK 3 million (9) in Q4. A disappointing end to the year, primarily as a result of negative organic... ► Artikel lesen | |
| 23.02. | Lundin Gold Inc.: Lundin Gold Reports Fourth Quarter and Full Year Results | 38 | GlobeNewswire (Europe) | Production and Cost Performance Meets Upgraded Guidance
VANCOUVER, BC, Feb. 22, 2024 /CNW/ - Lundin Gold Inc. (TSX: LUG; Nasdaq Stockholm: LUG; OTCQX: LUGDF) ("Lundin Gold" or the "Company") is pleased... ► Artikel lesen | |
| 23.02. | Abliva AB: Abliva AB Year-End Report January - December 2023 | 152 | GlobeNewswire (Europe) | 40 Patients Enrolled in Wave 1 of the FALCON Study | Fast Track Designation for KL1333 | Orphan Drug Designation for NV354 in both US and Europe
2023 SummaryImportant events during 2023KL1333The first... ► Artikel lesen | |
| 23.02. | SynAct Pharma AB: SynAct Pharma today publishes the fourth quarter and annual results of 2023 | 142 | GlobeNewswire (Europe) | "We have excellent opportunities before us, and we remain focused on delivering patient, company and shareholder value," said Torbjørn Bjerke, CEO.
October - December 2023The Group's net sales amounted... ► Artikel lesen | |
| 23.02. | Kancera AB: Interim Report Fourth Quarter 2023, October 1 - December 31 | 238 | GlobeNewswire (Europe) | The period in brief - financial summary for the fourth quarterNet sales amounted to SEK 0 million (SEK 0).R&D expenses amounted to SEK 17,1 million (SEK 11,6 million).Operating income amounted to SEK... ► Artikel lesen | |
| 23.02. | Edoc Acquisition Corp. Announces Postponement of Special Meeting of Stockholders on Proposed Business Combination | 380 | GlobeNewswire (Europe) | Victor, NY, Feb. 23, 2024 (GLOBE NEWSWIRE) -- EDOC Acquisition Corp. (Nasdaq: ADOC) ("EDOC") announced today that it has postponed its extraordinary general meeting of its shareholders (the "Meeting")... ► Artikel lesen | |
| 23.02. | Coherus BioSciences, Inc.: Coherus BioSciences Announces New Employment Inducement Grants | 484 | GlobeNewswire (Europe) | REDWOOD CITY, Calif., Feb. 23, 2024 (GLOBE NEWSWIRE) -- Coherus BioSciences, Inc. ("Coherus" or the "Company", Nasdaq: CHRS), today announced that effective February 20, 2024, the compensation committee... ► Artikel lesen | |
| 23.02. | Adamas One Corp.: Adamas One Receives Nasdaq Notification of Non-Compliance with Listing Rule 5250(c) | 417 | GlobeNewswire (Europe) | SCOTTSDALE, Ariz., Feb. 23, 2024 (GLOBE NEWSWIRE) -- Adamas One Corp. (Nasdaq: JEWL) ("Adamas One," "Adamas" or the "Company"), The Original Lab-Grown Diamond Company, a high-tech company that leverages... ► Artikel lesen | |
| 23.02. | NeuroOne Medical Technologies Corp: NeuroOne Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) | 410 | GlobeNewswire (Europe) | EDEN PRAIRIE, Minn., Feb. 23, 2024 (GLOBE NEWSWIRE) -- NeuroOne Medical Technologies Corporation (NASDAQ: NMTC) ("NeuroOne" or the "Company"), a medical technology company focused on improving surgical... ► Artikel lesen | |
| 23.02. | MoneyHero Limited: MoneyHero Group Appoints Rohith Murthy Chief Executive Officer | 436 | GlobeNewswire (Europe) | SINGAPORE, Feb. 23, 2024 (GLOBE NEWSWIRE) -- MoneyHero Limited (Nasdaq: MNY) ("MoneyHero" or the "Company"), a market-leading personal finance aggregation and comparison platform in Greater Southeast... ► Artikel lesen | |
| 23.02. | Celularity, Inc.: Celularity Announces 1-for-10 Reverse Stock Split | 440 | GlobeNewswire (Europe) | FLORHAM PARK, N.J., Feb. 23, 2024 (GLOBE NEWSWIRE) -- Celularity, Inc. (Nasdaq: CELU; CELUW) ("Celularity"), a biotechnology company developing allogeneic cell therapies and advanced biomaterial products... ► Artikel lesen | |
| 23.02. | Ultragenyx Pharmaceutical Inc.: Ultragenyx Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) | 242 | GlobeNewswire (Europe) | NOVATO, Calif., Feb. 23, 2024 (GLOBE NEWSWIRE) -- Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE), a biopharmaceutical company focused on the development and commercialization of novel therapies for... ► Artikel lesen | |
| 23.02. | TELA Bio, Inc.: TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) | 268 | GlobeNewswire (Europe) | MALVERN, Pa., Feb. 23, 2024 (GLOBE NEWSWIRE) -- TELA Bio, Inc. ("TELA Bio") (NASDAQ: TELA), a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction... ► Artikel lesen | |
| 23.02. | Mesa Air Group, Inc.: Mesa Air Group Discloses Notice from Nasdaq | 292 | GlobeNewswire (Europe) | PHOENIX, Feb. 23, 2024 (GLOBE NEWSWIRE) -- Mesa Air Group, Inc. (NASDAQ: MESA) ("Mesa" or the "Company") today announced that it received a notice ("Notice") on February 21, 2024 from the Listing... ► Artikel lesen | |
| 23.02. | Looking Glass Labs Ltd: Looking Glass Labs Welcomes Natasha Ingram as New CEO to Spearhead Innovative Open Metaverse Initiatives | 1.090 | GlobeNewswire (Europe) | VANCOUVER, British Columbia, Feb. 23, 2024 (GLOBE NEWSWIRE) -- Looking Glass Labs Ltd. ("LGL" or the "Company") (Cboe Canada: NFTX) (OTC: LGSLF) (FRA: H1N) a leading company in the Open Metaverse... ► Artikel lesen |
Seite:
1 2 3 4 Weiter >>
| Suchbegriffe der letzen 24 h | Anzahl |
|---|---|
| SUPER MICRO COMPUTER | 3.983 |
| EVOTEC | 3.178 |
| TUI | 2.803 |
| NVIDIA | 2.734 |
| BAYER | 2.659 |
| NEL | 2.469 |
| RENK GROUP | 1.788 |
| RHEINMETALL | 1.704 |
| TESLA | 1.302 |
| PALANTIR TECHNOLOGIES | 1.279 |
| VOLKSWAGEN | 1.265 |
| DEUTSCHE BANK | 1.151 |
| PLUG POWER | 1.068 |
| AMAZON | 1.043 |
| BYD | 1.043 |
| MICROSTRATEGY | 1.042 |
| PROSIEBENSAT.1 | 1.028 |
| BASF | 1.020 |
| COMMERZBANK | 1.019 |
| MERCEDES-BENZ | 948 |
| THYSSENKRUPP | 935 |
| JINKOSOLAR | 888 |
| ALLIANZ | 886 |
| AIXTRON SE | 879 |
| DEUTSCHE TELEKOM | 874 |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
